#crwd
- 1. Financial Performance:
• Revenue: Total revenue was $921.0 million, a 33% increase year-over-year.
• Subscription Revenue: Reached $872.2 million, up by 34% from the previous year.
• Annual Recurring Revenue (ARR): Grew 33% year-over-year to $3.65 billion.
• Net New ARR: Increased by 22% year-over-year to $211.7 million.
- 믿고있었다고 !!
- 1. Financial Performance:
• Revenue: Total revenue was $921.0 million, a 33% increase year-over-year.
• Subscription Revenue: Reached $872.2 million, up by 34% from the previous year.
• Annual Recurring Revenue (ARR): Grew 33% year-over-year to $3.65 billion.
• Net New ARR: Increased by 22% year-over-year to $211.7 million.
- 믿고있었다고 !!
Forwarded from 미국 제약-바이오 주식/약장수
2000 닷컴 버블과 현재의 AI 버블. 닷컴 버블과 달리 AI 버블은 펀더멘털의 뒷받침이 있다는…
================
약장수 리포트 구매 안내 https://t.me/yakjangsu/14598
================
약장수 리포트 구매 안내 https://t.me/yakjangsu/14598